We are live on
!
Find out more
CS
Candriam SCA Portfolio holdings
AUM
$19.3B
1-Year Est. Return
39.18%
This Fund
S&P 500
This Quarter
Est. Return
-8.4%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$4.07B
AUM Growth
-$732M
(-15%)
Cap. Flow
-$324M
Cap. Flow
% of AUM
-7.96%
Top 10 Holdings %
Top 10 Hldgs %
18.03%
Holding
679
New
46
Increased
261
Reduced
260
Closed
64
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nike
NKE
|
+$31.9M |
| 2 |
McKesson
MCK
|
+$27.5M |
| 3 |
Procter & Gamble
PG
|
+$27.1M |
| 4 |
Starbucks
SBUX
|
+$27M |
| 5 |
NVIDIA
NVDA
|
+$21M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$109M |
| 2 |
iShares US Real Estate ETF
IYR
|
+$31.3M |
| 3 |
EMC
EMC CORPORATION
EMC
|
+$24.7M |
| 4 |
SNI
Scripps Networks Interactive, Inc Common Class A
SNI
|
+$23.8M |
| 5 |
K
Kellanova
K
|
+$20.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 28.72% |
| 2 | Financials | 13.85% |
| 3 | Technology | 10.05% |
| 4 | Consumer Discretionary | 8.55% |
| 5 | Consumer Staples | 8.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MDCO
301
DELISTED
Medicines Co
MDCO
| $2.4M | 0.06% |
63,300
-16,700
| -21% | -$586K |
|
302
Telus
TU
$16B
| $2.38M | 0.06% |
151,914
-17,026
| -10% | -$283K |
|
|
ACHN
303
DELISTED
Achillion Pharmaceuticals
ACHN
| $2.38M | 0.06% |
344,300
-35,700
| -9% | -$291K |
|
|
ESPR
304
DELISTED
Esperion Therapeutics
ESPR
| $2.38M | 0.06% |
100,800
-59,200
| -37% | -$3.72M |
|
305
Kinder Morgan
KMI
$73.1B
| $2.37M | 0.06% |
85,504
+2,230
| +3% | +$73.8K |
|
306
Booking.com
BKNG
$138B
| $2.29M | 0.06% |
46,200
-20,300
| -31% | -$1.01M |
|
|
IMGN
307
DELISTED
Immunogen Inc
IMGN
| $2.29M | 0.06% |
238,100
-61,900
| -21% | -$905K |
|
308
Costco
COST
$415B
| $2.27M | 0.06% |
15,723
+1,221
| +8% | +$174K |
|
309
MacroGenics
MGNX
$235M
| $2.27M | 0.06% |
106,100
-27,900
| -21% | -$875K |
|
310
Boston Scientific
BSX
$65.8B
| $2.26M | 0.06% |
137,495
-294,891
| -68% | -$5.04M |
|
|
WBA
311
DELISTED
Walgreens Boots Alliance
WBA
| $2.22M | 0.05% |
26,705
+1,771
| +7% | +$160K |
|
|
EGN
312
DELISTED
Energen
EGN
| $2.21M | 0.05% |
44,411
+3,857
| +10% | +$208K |
|
|
CTIC
313
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $2.21M | 0.05% |
151,500
+7,000
| +5% | +$121K |
|
314
Zoetis
ZTS
$31.6B
| $2.2M | 0.05% |
53,525
+11,135
| +26% | +$516K |
|
315
Canadian Natural Resources
CNQ
$96.9B
| $2.2M | 0.05% |
234,979
+15,275
| +7% | +$168K |
|
|
BSMX
316
DELISTED
Banco Santander México, S, A., Institución de Banca Múltiple, Grupo Financiero Santander México
BSMX
| $2.2M | 0.05% |
+300,000
| New | +$2.49M |
|
317
HP
HPQ
$23.5B
| $2.18M | 0.05% |
187,793
+29,575
| +19% | +$384K |
|
318
Public Storage
PSA
$60.2B
| $2.18M | 0.05% |
10,307
+358
| +4% | +$72.9K |
|
319
T-Mobile US
TMUS
$193B
| $2.17M | 0.05% |
54,638
-2,364
| -4% | -$94.3K |
|
|
AVDL
320
DELISTED
Avadel Pharmaceuticals
AVDL
| $2.13M | 0.05% |
130,600
-1,400
| -1% | -$30.8K |
|
321
Bank of Montreal
BMO
$125B
| $2.12M | 0.05% |
38,952
+8,199
| +27% | +$450K |
|
|
AGEN
322
Agenus
AGEN
$249M
| $2.11M | 0.05% |
23,320
-2,665
| -10% | -$395K |
|
|
BXLT
323
DELISTED
BAXALTA INC COM STK (DE)
BXLT
| $2.1M | 0.05% |
+66,614
| New | +$2.3M |
|
324
AutoNation
AN
$6.97B
| $2.1M | 0.05% |
36,043
-115,282
| -76% | -$7.01M |
|
|
JOY
325
DELISTED
Joy Global Inc
JOY
| $2.08M | 0.05% |
+139,535
| New | +$3.38M |
|
Similar funds
PCM
A
MGP
LF
SOMRS
BPA
MIM
Candriam SCA's Q3 2015 Portfolio in Review
As of Q3 2015, Candriam SCA held 679 positions worth $4.07B, down 15% from $4.8B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Candriam SCA withdrew a net $324M in Q3 2015, closing 64 positions and reducing 260 holdings. Its most notable exit was Alphabet (Google) Class C, an estimated $109M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 29% a quarter earlier, followed by Financials and Technology.
Against the trend, Candriam SCA opened a new position in Masco worth $14.9M.
- Candriam SCA's largest Q3 2015 buy was Masco: 593,671 shares worth $14.9M.
- Candriam SCA added most to Nike in Q3 2015, an estimated $31.9M increase.
- Candriam SCA's biggest Q3 2015 reduction was iShares US Real Estate ETF, cutting an estimated $31.3M.
- Candriam SCA fully exited Alphabet (Google) Class C in Q3 2015, selling an estimated $109M.
- Candriam SCA's ten largest holdings make up 18% of its $4.07B portfolio in Q3 2015.
- Candriam SCA opened 46 new positions and closed 64 in Q3 2015.
- Candriam SCA's portfolio value fell 15% quarter-over-quarter to $4.07B.
Based on Candriam SCA's 13F filing for Q3 2015, filed 19 Oct 2015.